West Pharmaceutical Services WST Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Proprietary Products | $2.49B+6.8% | $2.33B-2.6% | $2.4B— | —— | |
| Concentration risk, percentage by Product | |||||
| Standard Packaging | 55%+7.0pp | 48%-9.0pp | 57%+5.0pp | 52%0.0pp | |
| Net Sales by Geography | |||||
| Other European countries | $451M+17.0% | $385.5M-0.7% | $388.1M+8.0% | $359.2M+5.2% | |
| Other | $353.3M+4.2% | $339M-2.7% | $348.5M-4.3% | $364.3M+1.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does West Pharmaceutical Services break its business down?
- West Pharmaceutical Services (WST) reports net sales by business across 2 parts — Proprietary Products and West Vantage. Each is extracted from the segment footnotes and tracked over time.
- Where does West Pharmaceutical Services's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in West Pharmaceutical Services's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
